Filter Results:
(1,655)
Show Results For
- All HBS Web
(1,655)
- People (11)
- News (516)
- Research (864)
- Events (1)
- Multimedia (9)
- Faculty Publications (365)
Show Results For
- All HBS Web
(1,655)
- People (11)
- News (516)
- Research (864)
- Events (1)
- Multimedia (9)
- Faculty Publications (365)
- Article
TDABC Cost Analysis of Ocular Disorders in an Ophthalmology Emergency Department versus Urgent Care: Clinical Experience at Massachusetts Eye and Ear
By: Robert S. Kaplan, Jonathan Chou, Mahek Shah, Amy Watts, Matthew Gardiner, Joan Miller and John I. Lowenstein
Purpose
To perform a cost analysis comparison for managing common ocular disorders in an eye emergency department (ED) versus an urgent care setting using a time-driven activity-based cost model (TDABC) to assist physicians and staff in appropriate allocation of... View Details
Keywords: Time-driven Activity-based Cost Model; Emergency Room; Urgent Care Clinic; Cost; Analysis; Activity Based Costing and Management; Health Care and Treatment
Kaplan, Robert S., Jonathan Chou, Mahek Shah, Amy Watts, Matthew Gardiner, Joan Miller, and John I. Lowenstein. "TDABC Cost Analysis of Ocular Disorders in an Ophthalmology Emergency Department versus Urgent Care: Clinical Experience at Massachusetts Eye and Ear." Journal of Academic Ophthalmology 10 (2018).
- Web
Drug & Alcohol Policy | About
Wellness and Health Promotion within Harvard University Health Services (HUHS). Faculty and staff members can learn about the dangers of substance abuse and get information... View Details
- December 2021
- Article
Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study
By: Michael Anne Kyle, Renuka Tipirneni, Nitya Thakore, Sneha Dave and Ishani Ganguli
Background
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Keywords: COVID-19; Ambulatory Care; Policy/economics; Access; Telemedicine; Health Pandemics; Health Care and Treatment
Kyle, Michael Anne, Renuka Tipirneni, Nitya Thakore, Sneha Dave, and Ishani Ganguli. "Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study." Journal of General Internal Medicine 36, no. 12 (December 2021): 3766–3771.
- 01 Nov 2022
- Research & Ideas
A Penny for Your Thoughts? For Big-Picture Ideas, the Right Pay Structure Matters
submitting ideas when considering promotions might also provide another incentive, as well as publicly recognizing innovative workers, Gallani suggests. “There is a little bit of a tradeoff between pay for performance and extra-role... View Details
Keywords: by Scott Van Voorhis
- 11 Apr 2017
- First Look
First Look at New Research, April 11
investors at all horizons. However, it also means that the scope for hedging liabilities using global bonds has increased, benefiting investors with long-dated liabilities. Finally, we show that the well documented negative stock-bond... View Details
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
its infrastructure for societal uses, or whether to exploit a commercial opportunity related to launching small, handheld cubesats. The case explores the basis for ISRO’s cost advantage vis-à-vis western entities, as well as its resource... View Details
Keywords: Sean Silverthorne
- 06 Sep 2022
- Blog Post
Student Spotlight: Summer Internships in Business & Environment
What are the career opportunities in business and environment? In Summer 2022, over 65 MBA students found internships at the intersection of business and the environment. This post provides a sample of some of the types of companies that students worked at this summer... View Details
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
to change your life. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=54720 in press Health Care Management Review Innovation Contest: Effect of Perceived Support for Learning on Participation By: Jung, Olivia S., Andrea... View Details
Keywords: Dina Gerdeman
- 15 Feb 2012
- Working Paper Summaries
Learning from My Success and From Others’ Failure: Evidence from Minimally Invasive Cardiac Surgery
- 15 Mar 2011
- First Look
First Look: March 15
tax policy. Teams and Team Effectiveness in Health Services Organizations Authors:Bruce J. Fried, Sharon Topping, and Amy C. Edmondson Publication:In Health Care Management: Organization Design and Behavior.... View Details
Keywords: Sean Silverthorne
- November 2023 (Revised April 2024)
- Case
BiomX: Bringing Phage Back to the Stage
By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Pharmaceutical Industry
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
- Web
Providers - Institute For Strategy And Competitiveness
Employers Suppliers Policymakers Providers Providers Every health care provider has the opportunity to dramatically increase value for patients . This means better care for less cost. By focusing on value, providers can increase... View Details
- 11 Aug 2003
- Research & Ideas
Why Budgeting Kills Your Company
relative-performance approach drives success. Each manager knows from the outset "what has to be done to improve his or her usual performance," Hope and Fraser write. But it is only in hindsight that they know how well they have... View Details
Keywords: by Loren Gary
- 18 Feb 2009
- First Look
First Look: February 18, 2009
case: http://harvardbusinessonline.hbsp.harvard.edu/ b01/en/common/item_detail.jhtml?id=609062 Syndexa and Technology Transfer at Harvard University Harvard Business School Case 808-073 Gokhan Hotamisligil is a star researcher at Harvard School of Public View Details
Keywords: Martha Lagace
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- 01 Jun 2023
- News
From Big Pharma to Startup
diagnosis and treatment with genomic sequencing and machine learning to solve antibiotic resistance Nix—develops biosensors that analyze electrochemical biomarkers to deliver health and wellness data to... View Details
Keywords: April White
- 23 Sep 2014
- First Look
First Look: September 23
http://hbr.org/product/Belk--Towards-Exceptional/an/415023-PDF-ENG Harvard Business School Case 915-002 Reinventing Retail: ShopRunner's Network Bet ShopRunner considers adjustments to improve its online shopping service, which offers no-charge two-day shipping as... View Details
Keywords: Sean Silverthorne
- Web
Teele Hall | About
and staffing new business schools in other countries, including IMEDE in Lausanne, Switzerland, and INSEAD in Paris, as well as programs at the University of Istanbul in Turkey and Keio University in Japan. A great believer in broadening... View Details
- 07 May 2024
- Blog Post
Opportunity to Offset Travel Emissions with Carbon Credits that Meet HBS Criteria
provide health and equity benefits. The remaining 0.5% is a modest investment in Frontier projects which is made up of promising, innovative, yet higher risk permanent carbon removal technologies ready to scale, which are important as... View Details